Role of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia

ObjectivesTo assess the feasibility and efficacy of prostatic artery embolization in relieving symptoms of benign prostatic hyperplasia.Materials and methodsIn a prospective study 28 patients with symptomatic benign prostatic hyperplasia were presented for prostatic artery embolization between June 2012 and June 2014. Patients age was 48–85 years with mean age 68.5 years ± 10.6 SD. International Prostate Symptoms Score (IPSS) before intervention measured 20–35 with mean score 26.3 ± 6.8 SD. Prostatic volume before intervention ranged between 48 and 166 cc3 with mean of 82.6 ± 11.2 SD.ResultsTechnical success was achieved in all cases (100%). All patients were followed for 6 months after the procedure. IPSS improved at 6 months in all patients with post embolization mean of 12.2 ± 3.4 SD with significant P value of 0.0006. Mean post-procedure prostatic volume at 6 months was 49.8 cc3 ± 16.9 SD with 39.7% mean volume reduction. No major complications were recorded. We achieved clinical success in 27 patients (96.4%) with only one non responding patient (3.6%).ConclusionProstatic artery embolization is a feasible technique and preliminary short-term results show promising high technical and clinical success rates in symptomatic patients with benign prostatic hyperplasia.